Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)

CNY 9.33

(0.0%)

Market Cap (In CNY)

1.13 Billion

Revenue (In CNY)

121.77 Million

Net Income (In CNY)

-38.27 Million

Avg. Volume

656.3 Thousand

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5.85-12.41
PE
-
EPS
-
Beta Value
0.178
ISIN
CNE000000BF3
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Bo Liu
Employee Count
-
Website
https://www.hztmyy.com
Ipo Date
1993-08-23
Details
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, granules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, fresh herbs, etc.; and provision of professional medical services, such as valet decoction and distribution, slicing, and powder grinding services, as well as Chinese medicine diagnosis and treatment services. In addition, the company engages in the software development, remote health management, commercial complex management, food, Internet information businesses, etc. Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd was founded in 1958 and is headquartered in Hangzhou, China.